Dr. Reddy's Laboratories Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Jul 22, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-private-issuer
TL;DR
DRL filed a 6-K, just standard paperwork for foreign companies.
AI Summary
Dr. Reddy's Laboratories Limited, based in Hyderabad, India, filed a Form 6-K on July 22, 2025. This report is a routine filing for a foreign private issuer and does not contain specific financial or operational updates beyond confirming their status and filing requirements.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' compliance with SEC reporting requirements as a foreign private issuer, which is standard for publicly traded international companies.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new material information.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-25-000478 (filing_id) — Accession Number
- July 22, 2025 (date) — Filing Date
- Hyderabad, India (location) — Company Headquarters
FAQ
What type of filing is this Form 6-K?
This is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
Who is the filer of this document?
The filer is Dr. Reddy's Laboratories Limited.
When was this Form 6-K filed?
The filing date was July 22, 2025.
Where is Dr. Reddy's Laboratories Limited headquartered?
The company is headquartered in Hyderabad, Telangana, India.
Does Dr. Reddy's Laboratories file an annual report under Form 20-F or 40-F?
Yes, Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 22, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).